These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12036450)

  • 1. Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas.
    Shigemasa K; Katoh O; Shiroyama Y; Mihara S; Mukai K; Nagai N; Ohama K
    Jpn J Cancer Res; 2002 May; 93(5):542-50. PubMed ID: 12036450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer.
    Baekelandt M; Holm R; Nesland JM; Tropé CG; Kristensen GB
    J Clin Oncol; 2000 Nov; 18(22):3775-81. PubMed ID: 11078490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
    Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
    Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental changes in expression of myeloid cell leukemia-1 in human germ cells during oogenesis and early folliculogenesis.
    Hartley PS; Bayne RA; Robinson LL; Fulton N; Anderson RA
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3417-27. PubMed ID: 12107261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of bcl-2, bax, mcl-1, and bcl-X expression in ovarian surface epithelial tumors.
    Wehrli BM; Krajewski S; Gascoyne RD; Reed JC; Gilks CB
    Int J Gynecol Pathol; 1998 Jul; 17(3):255-60. PubMed ID: 9656122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers.
    Miyamoto Y; Hosotani R; Wada M; Lee JU; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Doi R; Kato M; Shimada Y; Imamura M
    Oncology; 1999; 56(1):73-82. PubMed ID: 9885381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
    Krajewska M; Krajewski S; Epstein JI; Shabaik A; Sauvageot J; Song K; Kitada S; Reed JC
    Am J Pathol; 1996 May; 148(5):1567-76. PubMed ID: 8623925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and localization of Bcl-2 related proteins in human ovarian cancers.
    Witty JP; Jensen RA; Johnson AL
    Anticancer Res; 1998; 18(2B):1223-30. PubMed ID: 9615792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.
    Krajewski S; Krajewska M; Ehrmann J; Sikorska M; Lach B; Chatten J; Reed JC
    Am J Pathol; 1997 Mar; 150(3):805-14. PubMed ID: 9060818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer.
    Gu L; Shigemasa K; Ohama K
    Int J Oncol; 2004 Mar; 24(3):671-8. PubMed ID: 14767552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
    Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
    Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
    Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
    Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer.
    Shigemasa K; Gu L; Tanimoto H; O'Brien TJ; Ohama K
    Clin Cancer Res; 2004 Apr; 10(8):2766-70. PubMed ID: 15102682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the antiapoptotic Bcl-2 family member myeloid cell leukemia-1 (Mcl-1) and the stimulation of its message by gonadotropins in the rat ovary.
    Leo CP; Hsu SY; Chun SY; Bae HW; Hsueh AJ
    Endocrinology; 1999 Dec; 140(12):5469-77. PubMed ID: 10579309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2: bax and bcl-2: Bcl-x ratios by image cytometric quantitation of immunohistochemical expression in ovarian carcinoma: correlation with prognosis.
    Lohmann CM; League AA; Clark WS; Lawson D; DeRose PB; Cohen C
    Cytometry; 2000 Feb; 42(1):61-6. PubMed ID: 10679744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underexpression of cyclin-dependent kinase inhibitor p27 is associated with poor prognosis in serous ovarian carcinomas.
    Shigemasa K; Shiroyama Y; Sawasaki T; Fujii T; Nagai N; Parmley TH; O'Brien TJ; Ohama K
    Int J Oncol; 2001 May; 18(5):953-8. PubMed ID: 11295040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer.
    Marx D; Binder C; Meden H; Lenthe T; Ziemek T; Hiddemann T; Kuhn W; Schauer A
    Anticancer Res; 1997; 17(3C):2233-40. PubMed ID: 9216694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.
    Diebold J; Baretton G; Felchner M; Meier W; Dopfer K; Schmidt M; Löhrs U
    Am J Clin Pathol; 1996 Mar; 105(3):341-9. PubMed ID: 8602616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic index and apoptosis influencing proteins bcl-2, mcl-1, bax and caspases 3, 6 and 8 in pancreatic carcinoma.
    Virkajärvi N; Pääkkö P; Soini Y
    Histopathology; 1998 Nov; 33(5):432-9. PubMed ID: 9839167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma.
    Deininger MH; Weller M; Streffer J; Meyermann R
    Cancer; 1999 Nov; 86(9):1832-9. PubMed ID: 10547558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.